Use of Safety-Modified Retroviruses to Introduce Chemotherapy Resistance Sequences into Normal Hematopoietic Cells for Chemoprotection During the Therapy of Breast Cancer: A Pilot Trial. M.D. Anderson Cancer Center, Houston, Texas
- 10 February 1996
- journal article
- research article
- Published by Mary Ann Liebert Inc in Human Gene Therapy
- Vol. 7 (3) , 401-416
- https://doi.org/10.1089/hum.1996.7.3-401
Abstract
No abstract availableThis publication has 1 reference indexed in Scilit:
- Developing new drugs for ovarian cancer: A challenging task in a changing realityZeitschrift für Krebsforschung und Klinische Onkologie, 1984